avcpl
Bluelighter
http://news.dispensarypermits.com/the-fda-is-asking-for-comments-on-cannabis
The FDA is requesting interested persons to submit comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of the following 16 drug substances:
Cannabis and Cannabis-Related Substances
Cannabis plant and resin
Extracts and tinctures of cannabis
Delta-9-Tetrahydrocannabinol
Isomers of THC
Synthetic Cannabinoids
ADB-FUBINACA
FUB-AMB(MMB-FUBINACA_AMB-FUBINACA)
ADB-CHMINACA
CUMYL-4CN-BINACA
Fentanyls
Cyclopropyl fentanyl
Methoxyacetyl fentanyl
Ortho-fluorofentanyl
Parafluoro butyrfentanyl
Paramethoxybutyrfentanyl
(Meth)cathinone
N-ethylnorpentylone
Medicines
Tramadol
Pregabalin
These comments will be considered in preparing a response from the United States to the World Health Organization (WHO) regarding the abuse liability and diversion of these drugs. WHO will use this information to consider whether to recommend that certain international restrictions be placed on these drugs.
If you?d like to submit a comment, you can do so the following ways:
Electronic Submission:
Federal eRulemaking Portal ? https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https://www.regulations.gov will be posted to the docket unchanged.
Written/Paper Submission:
Mail/Hand delivery/Courier ? Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. All submissions received must include the Docket No. FDA-2018-N-3685.
HERE IS THE LINK:
https://www.regulations.gov/document?D=FDA_FRDOC_0001-8787
The FDA is requesting interested persons to submit comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of the following 16 drug substances:
Cannabis and Cannabis-Related Substances
Cannabis plant and resin
Extracts and tinctures of cannabis
Delta-9-Tetrahydrocannabinol
Isomers of THC
Synthetic Cannabinoids
ADB-FUBINACA
FUB-AMB(MMB-FUBINACA_AMB-FUBINACA)
ADB-CHMINACA
CUMYL-4CN-BINACA
Fentanyls
Cyclopropyl fentanyl
Methoxyacetyl fentanyl
Ortho-fluorofentanyl
Parafluoro butyrfentanyl
Paramethoxybutyrfentanyl
(Meth)cathinone
N-ethylnorpentylone
Medicines
Tramadol
Pregabalin
These comments will be considered in preparing a response from the United States to the World Health Organization (WHO) regarding the abuse liability and diversion of these drugs. WHO will use this information to consider whether to recommend that certain international restrictions be placed on these drugs.
If you?d like to submit a comment, you can do so the following ways:
Electronic Submission:
Federal eRulemaking Portal ? https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https://www.regulations.gov will be posted to the docket unchanged.
Written/Paper Submission:
Mail/Hand delivery/Courier ? Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. All submissions received must include the Docket No. FDA-2018-N-3685.
HERE IS THE LINK:
https://www.regulations.gov/document?D=FDA_FRDOC_0001-8787